Parallax Volatility Advisers
ADMA icon

Parallax Volatility Advisers’s ADMA Biologics ADMA Stock Holding History

Parallax Volatility Advisers’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35,188
Closed -$69K – 3190
2020
Q4 		$69K Sell
35,188
-17,425
-33% -$36.6K ﹤0.01% 3008
2020
Q3 		$126K Buy
+52,613
New +$144K ﹤0.01% 2671

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Parallax Volatility Advisers's ADMA Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of ADMA Biologics (ADMA) in Q1 2021, closing a stake of 35,188 shares — an estimated $69K sold.

Parallax Volatility Advisers first reported a position in ADMA in Q3 2020 and held it in 2 quarters. The position peaked at $126K in Q3 2020. 105 funds tracked by Wall St. Rank hold ADMA as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining ADMA Biologics position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 35,188 ADMA Biologics shares in Q1 2021, an estimated $69K.
  • Parallax Volatility Advisers first reported a position in ADMA Biologics in Q3 2020 and held it in 2 quarters.
  • Parallax Volatility Advisers's ADMA Biologics position peaked at $126K in Q3 2020.
  • 105 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.